0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 12
  • 8
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

6
16
18
38

PUBLISHED

0
0
1
38

PRODUCT TYPE

30
5
2
1

Search for: "Alpharx, Inc."

AlphaRx, Inc. - Product Pipeline Review - 2012

AlphaRx, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “AlphaRx, Inc. - Product Pipeline Review - 2012” provides data on the AlphaRx, Inc.’s research...

Published:  August 2012
Price:  From

UMeWorld Limited (formerly AlphaRx, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

Published:  August 2015
Price:  From

AlphaRx, Inc. - Product Pipeline Review - Q1 2011

AlphaRx, Inc. – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “AlphaRx, Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research...

Published:  March 2011
Price:  From

AlphaRx, Inc. (ALRX) - Financial and Strategic SWOT Analysis Review

Summary AlphaRX, Inc. (AlphaRx), formerly known as Logic Tech International Inc., is a specialty pharmaceutical company. It undertakes focuses on the development of novel therapeutic products to treat...

Published:  January 2013
Price:  From

AlphaRx, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

Published:  June 2013
Price:  From

Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential

“Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” provides key data, information and analysis of the major trends and issues in Nanotechnology...

Published:  December 2010
Price:  From

Ocular Inflammation - Pipeline Review, H2 2013

Ocular Inflammation - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ocular Inflammation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

Published:  October 2013
Price:  From

Klebsiella Infections - Pipeline Review, H2 2012

Klebsiella Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Klebsiella Infections - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

Published:  September 2012
Price:  From

Pneumonia - Pipeline Review, H1 2013

Pneumonia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pneumonia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  February 2013
Price:  From

Pneumonia - Pipeline Review, H2 2012

Pneumonia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Pneumonia - Pipeline Review, H2 2012', provides an overview of the Pneumonia therapeutic pipeline. This report provides information...

Published:  August 2012
Price:  From

Ocular Inflammation - Pipeline Review, H1 2013

Ocular Inflammation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ocular Inflammation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

Published:  April 2013
Price:  From

Pain - Pipeline Review, H2 2012

Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Pain - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  November 2012
Price:  From

Gram-Negative Bacterial Infections - Pipeline Review, H2 2012

Gram-Negative Bacterial Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Gram-Negative Bacterial Infections - Pipeline Review, H2 2012', provides an overview of the indication’s...

Published:  December 2012
Price:  From

Bacillus Anthracis Infections - Pipeline Review, H2 2012

Bacillus Anthracis Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Bacillus Anthracis Infections - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

Published:  October 2012
Price:  From

Mycobacterium Tuberculosis Infections - Pipeline Review, H2 2012

Mycobacterium Tuberculosis Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Mycobacterium Tuberculosis Infections - Pipeline Review, H2 2012', provides an overview of the indication’s...

Published:  September 2012
Price:  From

Ocular Inflammation - Pipeline Review, H2 2012

Ocular Inflammation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Ocular Inflammation - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

Published:  October 2012
Price:  From

Mycobacterium Infections - Pipeline Review, H2 2012

Mycobacterium Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Mycobacterium Infections - Pipeline Review, H2 2012', provides an overview of the Mycobacterium Infections therapeutic...

Published:  August 2012
Price:  From

Enterobacteriaceae Infections - Pipeline Review, H2 2012

Enterobacteriaceae Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Enterobacteriaceae Infections - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

Published:  October 2012
Price:  From

Bacterial Infections - Pipeline Review, H2 2012

Bacterial Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Bacterial Infections - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

Published:  December 2012
Price:  From

The Top 35 Central Nervous System Drug Delivery Technology Companies Worldwide

The modern history of drug delivery started with the founding of ALZA Corporation in 1968 by Dr Alejandro Zaffaroni His vision was to develop therapeutic systems that delivered drugs at controlled rates...

Published:  May 2009
Price:  From
Loading Indicator

Our Clients

  • Hexcel Corporation
  • Harrods Ltd.
  • Bayer AG
  • Google, Inc.
  • Boeing Company
  • Harley Davidson Motor Company
  • SwissCom AG